Status:Closed
Opening date: 20 April 2026
Closing date: 1 June 2026
In order to promote new clinically-oriented collaborative projects within the Maladies Rares Marseille community, the MarMaRa institute is extending its "incentive action" funding to translational research projects. The aim of this "incentive action - translational research project" call is to support new, innovative, high-quality projects based on collaboration between a MarMaRa-affiliated research structure and a clinical department or laboratory in an AP-HM hospital.
The Translational Research call concerns any research project involving healthy subjects or patients, including epidemiological, pathophysiological or social science aspects.
To encourage this new call, particular attention will be paid to new projects and new teams/new partnerships.
Each project can obtain up to €30,000 for a maximum duration of 12 months.
|
Titre du projet |
Partenaires |
Laboratoires - équipes |
|---|---|---|
| MicroRNAs: new biomarkers to understand phenotypic variability and predict disease progression in patients with Charcot-Marie-Tooth disease type 1A | FRANKEL Diane | MMG et CRMR |
|
Titre du projet |
Partenaires |
Laboratoires - équipes |
|---|---|---|
|
Predicting the risk of acute aortic event in ACTA2 gene related hereditary thoracic aortic diseases (HTAD): a genotype-phenotype study of the impact of the p.Pro335Arg ACTA2 variant in an affected family with severe aortic prognosis. |
ZAFFRAN Stéphane BAL Laurence, CRMR Marfan |
MMG |
| Investigating genetic and epigenetic determinants of anaemia severity in sickle cell disease |
EL NEMER Wassim FAUCHER Benoît, CRMR |
ADES |
Documents
